Pioglitazone is a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist which can reduce insulin resistance in liver, muscle and adipose tissue (34) and improve glucose and lipid metabolism (33). Here, PPARG is linked to Insulin resistance.